Acutus Medical Inc
NASDAQ:AFIB
Relative Value
The Relative Value of one AFIB stock under the Base Case scenario is 2.1522 USD. Compared to the current market price of 0.1055 USD, Acutus Medical Inc is Undervalued by 95%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
AFIB Competitors Multiples
Acutus Medical Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Acutus Medical Inc
NASDAQ:AFIB
|
3.1m USD | 0.2 | -0.1 | 0 | 0 | ||
US |
Abbott Laboratories
NYSE:ABT
|
183.3B USD | 4.5 | 32.5 | 19.2 | 28.6 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.3B USD | 18.5 | 68.2 | 55.9 | 70 | ||
US |
Stryker Corp
NYSE:SYK
|
124.2B USD | 5.9 | 36.9 | 24 | 29.6 | ||
IE |
Medtronic PLC
NYSE:MDT
|
108.5B USD | 3.4 | 25.8 | 13.7 | 19.4 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
107B USD | 7.3 | 60.5 | 30.9 | 45.6 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.6B USD | 3.5 | 56 | 18.8 | 39.7 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.6B EUR | 2.7 | 38.6 | 18.5 | 31.3 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
378.7B CNY | 11 | 33.4 | 29.1 | 29.1 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.3B USD | 8.4 | 36.3 | 26.3 | 28.5 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
51.3B USD | 13.5 | 80.5 | 59.9 | 78 |